We use cookies. You have options. Cookies help us keep the site running smoothly and inform some of our advertising, but if you’d like to make adjustments, you can visit our Cookie Notice page for more information.
We’d like to use cookies on your device. Cookies help us keep the site running smoothly and inform some of our advertising, but how we use them is entirely up to you. Accept our recommended settings or customise them to your wishes.
×

Blog - Health & Wellness

Latest Posts

There’s a New Paradigm in People-Based Marketing, and Pharma Marketers Need to Embrace It Now

The time to embrace people-based marketing in pharma is now—but how? Now more than ever, pharma marketers have an opportunity to build personal and direct relationships at scale and can find opportunities to leverage people-based marketing (PBM) to reach both consumers (patients, caregivers) and healthcare providers (HCPs) on a deeper level, and drive measurable results.
Topic: Health

Three Ways Health Brands Can Engage Today’s Patients

The proliferation of devices and always-on nature of consumer behavior has given healthcare marketers the ability to reach current and prospective patients 24/7. However, this virtually unlimited reach often means that patients are inundated with messages, many of which go unnoticed or ignored.
Topic: Health

Three Critical Ways to Revolutionize Your Pharma Email Approach

Over a four-part blog post series, I’ll explore each of these best practices to help pharma marketers revolutionize their current strategies to achieve marketing excellence. This first post focuses on the traditional approach to email, as many pharma marketers would like to move away from traditional email development.
Topic: Health | Email

How to Segment and Target HCPs by Phase

In recent years, marketers have shifted their health care professional (HCP) marketing strategy from a "market aggregation" approach, which essentially treats everyone the same way, to a more targeted approach.
Topic: Health

Beyond Price Wars: Using Copay Programs to Drive Adoption

The use of co-pay or coupon cards are typically considered for prescription drugs farther along in their life cycle, when there are either new entrants in the category or when generics of less-expensive biosimilar products become available. A logical thought in the latter case is “all else being equal, a patient and prescriber will prefer the branded product.”
Topic: Health